A Canadian cost-effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation compared with surgery, in intermediate and high-risk severe aortic stenosis patients

References

• Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62(11):1002–1012. doi:10.1016/j.jacc.2013.05.01523727214
   PubMed Web of Science ®Google Scholar
• Bakaeen FG, Rosengart TK, Carabello BA. Aortic stenosis. Ann Intern Med. 2017;166(1):ITC1–ITC16. doi:10.7326/AITC20170103028030676
   PubMedGoogle Scholar
• Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–1607. doi:10.1056/NEJMoa100823220961243
   PubMed Web of Science ®Google Scholar
• Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–2198. doi:10.1056/NEJMoa110351021639811
   PubMed Web of Science ®Google Scholar
• al. ADPJRMYSCJe. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;371(10):967–968. doi:10.1056/NEJMc1408396
   Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–1620. doi:10.1056/NEJMoa151461627040324
   PubMed Web of Science ®Google Scholar
• Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376(14):1321–1331. doi:10.1056/NEJMoa170045628304219
   PubMed Web of Science ®Google Scholar
• Kodali S, Thourani VH, White J, et al. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J. 2016;37(28):2252–2262. doi:10.1093/eurheartj/ehw11227190101
   PubMed Web of Science ®Google Scholar
• Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387(10034):2218–2225. doi:10.1016/S0140-6736(16)30073-327053442
   PubMed Web of Science ®Google Scholar
• Baron SJ, Wang K, House JA, et al. Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at intermediate risk. Circulation. 2019;139(7):877–888. doi:10.1161/CIRCULATIONAHA.118.03523630586747
   PubMed Web of Science ®Google Scholar
• Tam DY, Hughes A, Fremes SE, et al. A cost-utility analysis of transcatheter versus surgical aortic valve replacement for the treatment of aortic stenosis in the population with intermediate surgical risk. J Thorac Cardiovasc Surg. 2018;155(5):1978–1988 e1971. doi:10.1016/j.jtcvs.2017.11.11229454487
   PubMedGoogle Scholar
• Tam DY, Hughes A, Wijeysundera HC, Fremes SE. Cost-effectiveness of self-expandable transcatheter aortic valves in intermediate-risk patients. Ann Thorac Surg. 2018;106(3):676–683. doi:10.1016/j.athoracsur.2018.03.06929730344
   PubMedGoogle Scholar
• Health Quality Ontario. Transcatheter aortic valve implantation for treatment of aortic valve stenosis: a health technology assessment. Ont Health Technol Assess Ser. 2016;16(19):1–94.
   Google Scholar
• Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2477–2484. doi:10.1016/S0140-6736(15)60308-725788234
   PubMed Web of Science ®Google Scholar
• Herrmann HC, Thourani VH, Kodali SK, et al. One-year clinical outcomes with SAPIEN 3 transcatheter aortic valve replacement in high-risk and inoperable patients with severe aortic stenosis. Circulation. 2016;134(2):130–140. doi:10.1161/CIRCULATIONAHA.116.02279727400898
   PubMed Web of Science ®Google Scholar
• Ontario Ministry of Health and Long Term Care. Schedule of Benefits for Physician Services under the Health Insurance Act. Queen’s Printer for Ontario Ontario. 2015; c2002.
   Google Scholar
• EuroSCORE. Available from: http://www.euroscore.org/. Accessed March 8, 2019.
   Google Scholar
• Ontario Ministry of Health and Long Term Care. Drugs funded by Ontario Drug Benefit (ODB) program: e-formulary Toronto: queen’s Printer for Ontario, 2009-2010. Available from: https://www.formulary.health.gov.on.ca/formulary/. Accessed March 8, 2019.
   Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;70(2):252–289. doi:10.1016/j.jacc.2017.03.01128315732
   PubMed Web of Science ®Google Scholar
• Coyle D, Coyle K, Cameron C, et al. Cost-effectiveness of new oral anticoagulants compared with warfarin in preventing stroke and other cardiovascular events in patients with atrial fibrillation. Value Health. 2013;16(4):498–506. doi:10.1016/j.jval.2013.01.00923796283
   PubMed Web of Science ®Google Scholar
• Cost of a Standard Hospital Stay · CIHI. Available from: https://yourhealthsystem.cihi.ca/hsp/inbrief?lang=en#!/indicators/015/cost-of-a-standard-hospital-stay/;mapC1;mapLevel2;/. Accessed 36, 2019.
   Google Scholar
• Patient Cost Estimator. Canadian Institute for Health Information (CIHI). Available from: https://www.cihi.ca/en/patient-cost-estimator. Accessed 1026, 2016.
   Google Scholar
• Hospital Inpatient Care Case Costs - CMG/Plex - Open Government.
   Google Scholar
• Consumer Price Index, monthly, not seasonally adjusted. Available from: https://www150.statcan.gc.ca/t1/tbl1/en/cv.action?pid=1810000401. Accessed March 8, 2019.
   Google Scholar
• Bansback N, Tsuchiya A, Brazier J, Anis A. Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies. PLoS One. 2012;7(2):e31115. doi:10.1371/journal.pone.003111522328929
   PubMed Web of Science ®Google Scholar
• Tengs TO, Lin TH. A meta-analysis of quality-of-life estimates for stroke. Pharmacoeconomics. 2003;21(3):191–200. doi:10.2165/00019053-200321030-0000412558469
   PubMed Web of Science ®Google Scholar
• Asgar A, Lambert L, Lauck S, et al. Canadian Cardiovascular Society National Quality Report: Transcatheter Aortic Valve Implantation. Canadian Cardiovascular Society. Ottawa. 2016.
   Google Scholar
• Fairbairn TA, Meads DM, Hulme C, et al. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk. Heart. 2013;99(13):914–920. doi:10.1136/heartjnl-2013-30372223696198
   PubMed Web of Science ®Google Scholar
• Gada H, Kapadia SR, Tuzcu EM, Svensson LG, Marwick TH. Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients. Am J Cardiol. 2012;109(9):1326–1333. doi:10.1016/j.amjcard.2011.12.03022335853
   PubMedGoogle Scholar
• Reynolds MR, Lei Y, Wang K, et al. Cost-effectiveness of transcatheter aortic valve replacement with a self-expanding prosthesis versus surgical aortic valve replacement. J Am Coll Cardiol. 2016;67(1):29–38. doi:10.1016/j.jacc.2015.10.04626764063
   PubMedGoogle Scholar
• Reynolds MR, Magnuson EA, Lei Y, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol. 2012;60(25):2683–2692. doi:10.1016/j.jacc.2012.09.01823122802
   PubMed Web of Science ®Google Scholar
• Fatehi Hassanabad A, Vasanthan V, Kent WDT. Minimally invasive surgical aortic valve replacement: an overview of recent advances. Can J Cardiol. 2019;35(2):225–228. doi:10.1016/j.cjca.2018.11.02730760431
   PubMedGoogle Scholar
• Mittmann N, Seung SJ, Hill MD, et al. Impact of disability status on ischemic stroke costs in Canada in the first year. Can J Neurol Sci. 2012;39(6):793–800.23041400
   PubMed Web of Science ®Google Scholar
• Blackhouse G, Assasi N, Xie F, et al. Cost-effectiveness of catheter ablation for rhythm control of atrial fibrillation. Int J Vasc Med. 2013;2013:262809.24089640
   PubMedGoogle Scholar
• Sullivan PW, Arant TW, Ellis SL, Ulrich H. The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US. Pharmacoeconomics. 2006;24(10):1021–1033. doi:10.2165/00019053-200624100-0000917002484
   PubMed Web of Science ®Google Scholar